UNSPSC 51283107: Caspofungin acetate

This classification denotes an antifungal agent with the molecular formula C52H88N10O15.2C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VUW370O5QE, chemically known as pneumocandin b0, 1-((4r,5s)-5-((2-aminoethyl)amino)-n2-(10,12-dimethyl-1-oxotetradecyl)-4-hydroxy-l-ornithine)-5-((3r)-3-hydroxy-l-ornithine)-, diacetate (salt) but more generally known as caspofungin acetate, which bears US NIH Compound Identifier 123623. The base compound, Caspofungin, most often comes in base and acetate forms.

UNSPSC 51283107 Caspofungin acetate (Commodity) represents a pharmaceutical product line, but the recent state and local opportunities tagged under this code show little alignment with caspofungin itself—an antifungal agent used in clinical settings. Instead, the opportunities reflect broader pharmaceutical procurement patterns, including antibiotic tablets and emergency-response medications such as naloxone, suggesting that state and local agencies may be using the code as a proxy for general pharmaceutical supply or that the tagging reflects administrative categorization rather than precise commodity matching. The work being solicited under this code encompasses pharmaceutical warehouse supply agreements, emergency medication procurement, and pharmaceutical distribution through cooperative purchasing vehicles and competitive bidding processes.

Activity under the code spans state health departments and county government procurement offices, with recent opportunities from the Illinois Department of Public Health and Seminole County, Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over three years (12-month initial term with two renewal options) for antibiotic tablets under an IFB process. Seminole County, Florida solicited naloxone and drug deactivation systems through competitive bidding (IFB60459723LAS, response deadline July 26, 2023) for quarterly delivery of 1,900 units of naloxone and 800 safe drug deactivation systems annually to the Seminole County Community Health Building. Recent activity concentrates in Florida and Illinois; the mix reflects state-level health department procurement alongside county public health initiatives, often leveraging cooperative purchasing agreements and fixed-fee or unit-cost models with multi-year terms and renewal options.